Skip to content

    PTC THERAPEUTICS (PTCT) stock price & financials

    View PTCT earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+40.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $196.79M
    $213.17M
    $1.18B
    $178.88M
    $211.01M
    +7.2%
    $164.68M
    -22.7%
    $272.55M
    -76.8%
    $360.52M
    +101.5%
    Stable
    Operating Profit
    -$54.51M
    -$162.39M
    $970.23M
    -$34.96M
    $3.02M
    -$71.35M
    +56.1%
    $44.96M
    -95.4%
    $148.98M
    Weakening
    Net Profit
    -$106.65M
    -$65.89M
    $866.56M
    -$64.85M
    $15.90M
    -$134.97M
    -104.8%
    -$2.81M
    -100.3%
    $83.50M
    Weakening
    EPS
    $-1.39
    $11.09
    $-0.83
    $0.20
    $-0.03
    -100.3%
    $1.01
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    -$97.99M
    -$94.70M
    $929.83M
    -$71.05M
    -$23.07M
    +76.5%
    -$139.08M
    -46.9%
    -$2.46M
    -100.3%
    $97.55M
    Weakening
    MarginsOPM
    -27.7%
    -76.2%
    82.5%
    -19.5%
    1.4%
    -43.3%
    +43.1%
    16.5%
    -80.0%
    41.3%
    Weakening
    Tax
    -8.8%
    30.4%
    6.8%
    8.7%
    168.9%
    3.0%
    -90.3%
    -14.1%
    -307.2%
    14.4%
    +64.9%
    Weakening
    ReturnsROIC
    2.6%
    1.6%
    -21.3%
    1.6%
    -0.4%
    -114.9%
    3.3%
    +104.8%
    0.1%
    -2.1%
    -228.8%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$169.50M$288.03M$208.81M$189.72M$279.83M$594.00M$779.71M$984.65M$1.05B
    Short-Term Investments$58.09M$398.54M$894.84M$583.66M$130.87M$282.74M$359.99M$960.72M$1.18B
    Total Current Assets$320.86M$779.28M$1.23B$954.37M$693.78M$1.22B$1.37B$2.27B$2.62B
    Net PP&E$12.69M$35.24M$118.24M$130.01M$175.02M$178.99M$117.66M$135.42M$126.27M
    Goodwill$82.34M$82.34M$82.34M$82.34M$82.34M$82.34M$82.34M$82.34M$82.34M
    Intangibles$701.03M$710.50M$715.33M$724.84M$705.89M$379.50M$118.79M$388.75M$402.93M
    Total Assets$1.12B$1.62B$2.21B$1.94B$1.71B$1.90B$1.71B$2.90B$3.25B
    LiabilitiesTotal Current Liabilities$166.80M$235.86M$277.33M$509.35M$406.24M$603.10M$580.98M$968.43M$771.07M
    Short-Term Debt$11.67M$20.00M$149.54M$286.63M$55.45M
    Long-Term Debt$141.35M$293.86M$309.14M$281.89M$571.72M$284.21M$285.41M$535.52M
    Long-Term Leases$9.02M$79.50M$73.62M$100.86M$97.63M$74.95M$93.58M$87.53M
    Total Liabilities$768.50M$1.03B$1.73B$1.94B$2.05B$2.71B$2.80B$3.10B$3.42B
    EquityCommon Stock & APIC$51.0K$62.0K$70.0K$71.0K$72.0K$75.0K$77.0K$80.0K$82.0K
    Retained Earnings-$938.92M-$1.19B-$1.63B-$2.10B-$2.66B-$3.28B-$3.65B-$2.96B-$2.88B
    Total Equity$350.73M$594.33M$481.98M$1.44M-$347.09M-$818.55M-$1.10B-$205.31M-$165.36M
    HighlightsNet Cash / (Debt)$74.57M$372.70M$341.94M$1.64B

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$27.64M-$98.64M-$194.07M-$251.33M-$356.65M-$158.42M-$107.69M$711.20M-$30.50M
    Cash from Investing-$42.61M-$387.24M-$561.55M$219.18M$290.18M-$176.74M$44.18M-$861.98M-$471.91M
    Cash from Financing$131.57M$613.21M$668.72M$20.88M$167.95M$646.40M$255.87M$331.09M$536.00M
    SummaryCapital Expenditure-$7.10M-$13.76M-$17.84M-$28.21M-$32.02M-$28.44M-$6.50M-$8.86M-$9.28M
    Free Cash Flow-$34.74M-$112.40M-$211.91M-$279.55M-$388.67M-$186.86M-$114.19M$702.34M-$39.78M
    FCF Margin-13.1%-36.6%-55.7%-51.9%-55.6%-19.9%-14.2%40.6%-3.9%

    Ratios